| abstract |
The present invention is directed to a 2,4-bis(trifluoroethoxy)pyridine compound represented by formula (1) : (see formula 1) (wherein X1 represents a fluorine atom or a hydrogen atom) or a salt thereof, and to a medicine containing the compound or the salt as an active ingredient. The compound has metabolic resistance in human liver microsome, good absorbability upon oral administration, and excellent ACAT inhibitory activity. |